Information About Additional Medical Products (non-MPA) From New England Compounding Center
Oct 2012 As part of its ongoing investigation of the multistate outbreak of fungal meningitis and other infections, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to investigate illnesses and test products from the New England Compounding Center (NECC). NECC is the same firm that distributed and recalled injectable steroid medications implicated in the ongoing multistate outbreak.
Information About Voluntary Recall of All Ameridose Medical Products
Oct 2012 The U.S. Food and Drug Administration announced that Ameridose, LLC, based in Westborough, Mass., voluntarily recalled all of its unexpired products in circulation. Ameridose is a company sharing common management by the same parties as New England Compounding Center (NECC) of Framingham, Mass., the firm associated with compounded drugs linked to the ongoing multistate outbreak of fungal meningitis and other infections.
CDC Resources
- Multistate Outbreak of Fungal Meningitis and Other Infections
- Health Alert Network Announcements
- CDC Health Alert Network (HAN): Update: Multistate Outbreak of Fungal Infections among Persons Who Received Injections with Contaminated Medication Dec 20, 2012
- CDC Health Alert Network (HAN): Update: Additional Contamination Identified in Medical Products from New England Compounding Center Dec 3, 2012
- CDC Health Alert Network (HAN): Contamination Identified in Additional Medical Products from New England Compounding Center NOV 1, 2012
- CDC Health Alert Network (HAN): Voluntary Recall of All Ameridose Medical Products NOV 1, 2012
- Publications and Resources
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC–INFO
